 Safety AEs will be evaluated using the Common Terminology Criteria for Adverse Events CTCAE of the US National Cancer Institute NCI version 4.0 20. Grade 3 or 4 AEs and serious adverse events SAEs will be assessed to determine the safety and tolerability of the various combinations of drugs. 